These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
550 related items for PubMed ID: 19428836
1. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague. Amemiya K, Meyers JL, Rogers TE, Fast RL, Bassett AD, Worsham PL, Powell BS, Norris SL, Krieg AM, Adamovicz JJ. Vaccine; 2009 Apr 06; 27(16):2220-9. PubMed ID: 19428836 [Abstract] [Full Text] [Related]
2. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague. Williamson ED, Stagg AJ, Eley SM, Taylor R, Green M, Jones SM, Titball RW. Vaccine; 2007 Jan 22; 25(6):1142-8. PubMed ID: 17101198 [Abstract] [Full Text] [Related]
3. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice. Uppada SB, Bhat AA, Sah A, Donthamshetty RN. Vaccine; 2011 Nov 21; 29(50):9352-60. PubMed ID: 22001881 [Abstract] [Full Text] [Related]
4. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Leary SE, Griffin KF, Garmory HS, Williamson ED, Titball RW. Microb Pathog; 1997 Sep 21; 23(3):167-79. PubMed ID: 9281474 [Abstract] [Full Text] [Related]
5. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis. Gupta G, Khan AA, Rao DN. Scand J Immunol; 2010 Mar 21; 71(3):186-98. PubMed ID: 20415784 [Abstract] [Full Text] [Related]
6. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270. Qi Z, Zhou L, Zhang Q, Ren L, Dai R, Wu B, Wang T, Zhu Z, Yang Y, Cui B, Wang Z, Wang H, Qiu Y, Guo Z, Yang R, Wang X. Vaccine; 2010 Feb 10; 28(6):1655-60. PubMed ID: 20079562 [Abstract] [Full Text] [Related]
7. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity. Eyles JE, Butcher WA, Titball RW, Hill J. Vaccine; 2007 Oct 16; 25(42):7301-6. PubMed ID: 17869388 [Abstract] [Full Text] [Related]
8. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery. Tripathi V, Chitralekha KT, Bakshi AR, Tomar D, Deshmukh RA, Baig MA, Rao DN. Vaccine; 2006 Apr 12; 24(16):3279-89. PubMed ID: 16476510 [Abstract] [Full Text] [Related]
9. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates. Williamson ED, Flick-Smith HC, Waters E, Miller J, Hodgson I, Le Butt CS, Hill J. Microb Pathog; 2007 Jan 12; 42(1):11-21. PubMed ID: 17107769 [Abstract] [Full Text] [Related]
10. Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague. Williamson ED, Packer PJ, Waters EL, Simpson AJ, Dyer D, Hartings J, Twenhafel N, Pitt ML. Vaccine; 2011 Jun 24; 29(29-30):4771-7. PubMed ID: 21570437 [Abstract] [Full Text] [Related]
11. Cell-mediated immune response to epitopic MAP (multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model. Shreewastav RK, Ali R, Uppada JB, Rao DN. Cell Immunol; 2012 Jun 24; 278(1-2):55-62. PubMed ID: 23121976 [Abstract] [Full Text] [Related]
12. A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague. Chichester JA, Musiychuk K, Farrance CE, Mett V, Lyons J, Mett V, Yusibov V. Vaccine; 2009 May 26; 27(25-26):3471-4. PubMed ID: 19200825 [Abstract] [Full Text] [Related]
13. Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice. Little SF, Webster WM, Wilhelm H, Fisher D, Norris SL, Powell BS, Enama J, Adamovicz JJ. Vaccine; 2010 Jan 22; 28(4):934-9. PubMed ID: 19925906 [Abstract] [Full Text] [Related]
14. Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague. Reed DS, Martinez MJ. Vaccine; 2006 Mar 20; 24(13):2283-9. PubMed ID: 16377037 [Abstract] [Full Text] [Related]
15. Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the Yersinia pestis Plague rF1V Vaccine. Biryukov S, Dankmeyer JL, Shamsuddin Z, Velez I, Rill NO, Rosario-Acevedo R, Klimko CP, Shoe JL, Hunter M, Ward MD, Cazares LH, Fetterer DP, Bozue JA, Worsham PL, Cote CK, Amemiya K. Front Immunol; 2021 Mar 20; 12():726416. PubMed ID: 34512658 [Abstract] [Full Text] [Related]
16. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague. Zauberman A, Cohen S, Levy Y, Halperin G, Lazar S, Velan B, Shafferman A, Flashner Y, Mamroud E. Vaccine; 2008 Mar 20; 26(13):1616-25. PubMed ID: 18304706 [Abstract] [Full Text] [Related]
17. Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model. Ali R, Naqvi RA, Kumar S, Bhat AA, Rao DN. Scand J Immunol; 2013 May 20; 77(5):361-71. PubMed ID: 23480362 [Abstract] [Full Text] [Related]
18. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague. Arnaboldi PM, Sambir M, D'Arco C, Peters LA, Seegers JF, Mayer L, McCormick AA, Dattwyler RJ. Vaccine; 2016 Nov 11; 34(47):5768-5776. PubMed ID: 27745954 [Abstract] [Full Text] [Related]
19. Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague. Leary SE, Griffin KF, Galyov EE, Hewer J, Williamson ED, Holmström A, Forsberg A, Titball RW. Microb Pathog; 1999 Mar 11; 26(3):159-69. PubMed ID: 10089156 [Abstract] [Full Text] [Related]